While inhibition of mTORC1 alone with rapamycin had no effect on NK cell viability, inhibition of both mTORC1 and cMyc signalling following BCH treatment resulted in a dramatic decrease in NK cell viability (Figure 8i). This evidence concerns the gene MYC and choreatic disease.